Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Atkinson

Showing results (571-580 of 730) with videos related to

Pageof 73
Sort By:
JAMA|May 18, 2000
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod TrialD G Sherman, R P Atkinson, T Chippendale, et al.
CJEM|June 6, 2017
International Federation for Emergency Medicine Consensus Statement: Sonography in hypotension and cardiac arrest (SHoC): An international consensus on the use of point of care ultrasound for undifferentiated hypotension and during cardiac arrest - CORRIGENDUMP Atkinson, J Bowra, J Milne, et al.
Nanotechnology|January 3, 2023
Effect of surface gallium termination on the formation and emission energy of an InGaAs wetting layer during the growth of InGaAs quantum dots by droplet epitaxyD Fricker, P Atkinson, X Jin, et al.
The Journal of Biological Chemistry|October 26, 1999
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertasesM Krych-Goldberg, R E Hauhart, V B Subramanian, et al.
International Immunology|May 1, 1995
Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' seraT Seya, T Hara, K Iwata, et al.
Immunogenetics|January 1, 1982
H-2 S region determined polymorphic variants of the C4, Slp, C2, and B complement proteins: a compilationJ P Atkinson, D R Karp, E P Seeskin, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 6, 1984
The C4 and Slp genes of the complement region of the murine H-2 major histocompatibility complexD C Shreffler, J P Atkinson, A C Chan, et al.
Immunology|June 1, 1990
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46D F Purcell, I F McKenzie, D M Lublin, et al.
The Journal of Biological Chemistry|October 17, 2003
A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertasesLisa A Kuttner-Kondo, Megan P Dybvig, Lynne M Mitchell, et al.
Human Pathology|March 5, 2023
Liver pathology in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: vasculopathic disease beyond nodular regenerative hyperplasiaPooja Khonde, Deyali Chatterjee, Madonna Bogacki, et al.
Pageof 73

Showing results (571-580 of 730) with videos related to

Sort By:
Pageof 73
JAMA|May 18, 2000
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod TrialD G Sherman, R P Atkinson, T Chippendale, et al.
CJEM|June 6, 2017
International Federation for Emergency Medicine Consensus Statement: Sonography in hypotension and cardiac arrest (SHoC): An international consensus on the use of point of care ultrasound for undifferentiated hypotension and during cardiac arrest - CORRIGENDUMP Atkinson, J Bowra, J Milne, et al.
Nanotechnology|January 3, 2023
Effect of surface gallium termination on the formation and emission energy of an InGaAs wetting layer during the growth of InGaAs quantum dots by droplet epitaxyD Fricker, P Atkinson, X Jin, et al.
The Journal of Biological Chemistry|October 26, 1999
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertasesM Krych-Goldberg, R E Hauhart, V B Subramanian, et al.
International Immunology|May 1, 1995
Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' seraT Seya, T Hara, K Iwata, et al.
Immunogenetics|January 1, 1982
H-2 S region determined polymorphic variants of the C4, Slp, C2, and B complement proteins: a compilationJ P Atkinson, D R Karp, E P Seeskin, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 6, 1984
The C4 and Slp genes of the complement region of the murine H-2 major histocompatibility complexD C Shreffler, J P Atkinson, A C Chan, et al.
Immunology|June 1, 1990
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46D F Purcell, I F McKenzie, D M Lublin, et al.
The Journal of Biological Chemistry|October 17, 2003
A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertasesLisa A Kuttner-Kondo, Megan P Dybvig, Lynne M Mitchell, et al.
Human Pathology|March 5, 2023
Liver pathology in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: vasculopathic disease beyond nodular regenerative hyperplasiaPooja Khonde, Deyali Chatterjee, Madonna Bogacki, et al.
Pageof 73